Zhitu Zhu

1.8k total citations
46 papers, 943 citations indexed

About

Zhitu Zhu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhitu Zhu has authored 46 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhitu Zhu's work include Metabolomics and Mass Spectrometry Studies (9 papers), Gastric Cancer Management and Outcomes (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Zhitu Zhu is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Gastric Cancer Management and Outcomes (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Zhitu Zhu collaborates with scholars based in China, Saint Kitts and Nevis and Japan. Zhitu Zhu's co-authors include Yunpeng Liu, Hongzhi Sun, Xiujuan Qu, Xiaohong Jin, Zhenghua Wang, Qingjun Wang, Yun‐Feng Cao, Yang Liu, Feng Li and Jian Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zhitu Zhu

45 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhitu Zhu China 17 595 195 177 109 84 46 943
Donghui Zhou China 17 909 1.5× 157 0.8× 160 0.9× 137 1.3× 140 1.7× 53 1.4k
Yuan Zhou China 22 490 0.8× 166 0.9× 169 1.0× 68 0.6× 156 1.9× 58 1.2k
Sarah Yoon South Korea 15 574 1.0× 180 0.9× 286 1.6× 79 0.7× 118 1.4× 22 918
Hailin Zhang China 15 562 0.9× 218 1.1× 253 1.4× 169 1.6× 128 1.5× 56 1.1k
Zhenzhou Yang China 18 531 0.9× 231 1.2× 213 1.2× 165 1.5× 44 0.5× 24 867
Lei Bi China 17 543 0.9× 218 1.1× 215 1.2× 123 1.1× 95 1.1× 46 977

Countries citing papers authored by Zhitu Zhu

Since Specialization
Citations

This map shows the geographic impact of Zhitu Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhitu Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhitu Zhu more than expected).

Fields of papers citing papers by Zhitu Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhitu Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhitu Zhu. The network helps show where Zhitu Zhu may publish in the future.

Co-authorship network of co-authors of Zhitu Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhitu Zhu. A scholar is included among the top collaborators of Zhitu Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhitu Zhu. Zhitu Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xue, Qi Yang, Li Leng, Peng Yang, & Zhitu Zhu. (2025). Altered metabolic profiles in colon and rectal cancer. Scientific Reports. 15(1). 11310–11310. 1 indexed citations
2.
Wu, Lingying, Xiaofan Li, Mei Feng, et al.. (2024). Efficacy and safety of enlonstobart (SG001), a PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer: A multicenter, single-arm, open-label, phase II study.. Journal of Clinical Oncology. 42(16_suppl). 5526–5526. 4 indexed citations
3.
Wang, Yuanyuan, et al.. (2022). Study on plasma amino acids and piperonamide as potential diagnostic biomarkers of non-small cell lung cancer. Translational Cancer Research. 11(5). 1269–1284. 8 indexed citations
4.
Hu, Xin, et al.. (2021). Alteration of Ornithine Metabolic Pathway in Colon Cancer and Multivariate Data Modelling for Cancer Diagnosis. ONCOLOGIE. 23(2). 203–217. 3 indexed citations
5.
Zhang, Yong, Yanhan Dong, Zhuo Xiong, et al.. (2020). Sirt6-Mediated Endothelial-to-Mesenchymal Transition Contributes Toward Diabetic Cardiomyopathy via the Notch1 Signaling Pathway. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Zhu, Zhitu, et al.. (2019). Prognostic significance of preoperative albumin-to-globulin ratio and prognostic nutritional index combined score in Siewert type 3 adenocarcinoma of esophagogastric junction. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Cao, Yun‐Feng, Qingjun Wang, Peng Gao, et al.. (2016). A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection. OncoTargets and Therapy. 9. 1389–1389. 77 indexed citations
8.
Wang, Jian, et al.. (2016). The History of Telocyte Discovery and Understanding. Advances in experimental medicine and biology. 913. 1–21. 19 indexed citations
9.
Zhong, Zhenyu, et al.. (2016). Effect of metformin on the proliferation and apoptosis of the renal cancer cell line 786-O and the underlying mechanisms.. PubMed. 20(5). 1244–9. 4 indexed citations
10.
Wang, Jian, Feng Li, Zhitu Zhu, et al.. (2015). Aquaporins as diagnostic and therapeutic targets in cancer: How far we are?. Journal of Translational Medicine. 13(1). 96–96. 106 indexed citations
11.
Li, Xin, Ling Xu, Heming Li, et al.. (2015). Cetuximab-induced insulin-like growth factor receptor I activation mediates cetuximab resistance in gastric cancer cells. Molecular Medicine Reports. 11(6). 4547–4554. 6 indexed citations
12.
Wang, Qian, Ce Li, Zhitu Zhu, et al.. (2015). miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells. Anti-Cancer Drugs. 27(1). 9–16. 28 indexed citations
13.
Jin, Xiaohong, et al.. (2014). Metastasis mechanism and gene/protein expression in gastric cancer with distant organs metastasis. Bulletin du Cancer. 101(1). 1–12. 59 indexed citations
14.
15.
Zhou, Jiebai, Zhitu Zhu, Chunxue Bai, Hongzhi Sun, & Xiangdong Wang. (2014). Proteomic profiling of lymphocytes in autoimmunity, inflammation and cancer. Journal of Translational Medicine. 12(1). 6–6. 14 indexed citations
16.
Li, Heming, Ling Xu, Lei Zhao, et al.. (2014). Insulin-like growth factor-I induces epithelial to mesenchymal transition via GSK-3β and ZEB2 in the BGC-823 gastric cancer cell line. Oncology Letters. 9(1). 143–148. 38 indexed citations
17.
Qu, Jinglei, Xin Li, Xiujuan Qu, et al.. (2013). Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer. PLoS ONE. 8(12). e83196–e83196. 15 indexed citations
18.
Zhu, Zhitu, Sa Deng, Hongzhi Sun, et al.. (2012). Isolation and identification of phase I metabolites of resibufogenin in rats. Xenobiotica. 43(5). 479–485. 11 indexed citations
19.
Yan, Shunchao, Xiujuan Qu, Zhitu Zhu, et al.. (2012). Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. Journal of Cancer Research and Clinical Oncology. 138(8). 1279–1289. 53 indexed citations
20.
Zhu, Zhitu, Bo Jin, Yunpeng Liu, et al.. (2006). [Enhancement of all-trans retinoic acid-induced differentiation by bufalin in primary culture of acute promyelocytic leukemia cells].. PubMed. 45(4). 314–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donghui Zhou Breakdown of academic impact, for papers by Yuan Zhou Breakdown of academic impact, for papers by Sarah Yoon Breakdown of academic impact, for papers by Hailin Zhang Breakdown of academic impact, for papers by Zhenzhou Yang Breakdown of academic impact, for papers by Lei Bi
Rankless by CCL
2026